Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alimemazine 1.5mg/5ml oral solution
0304010Y0AABABA
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
|
Alimemazine 10mg/5ml oral solution
0304010Y0AAAYAY
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
|
Alimemazine 15mg/5ml oral solution
0304010Y0AAAUAU
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
|
Alimemazine 5mg/5ml oral solution
0304010Y0AAAVAV
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
|
Alimemazine 5mg/5ml oral suspension
0304010Y0AAAZAZ
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | No data available |
|
Allens Chesty Cough oral solution
030902000BEDBA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
Allens Dry Tickly Cough oral solution
030902000BEDCA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
Allens Pine and Honey Balsam oral solution
030902000BECLA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
ALLERcalm Allergy Relief 4mg tablets
0304010G0BMAAAC
|
ALLERcalm | Chlorphenamine maleate | Respiratory System | No data available |
|
Allergy Relief 8mg capsules
0304010A0BDAAAA
|
Allergy Relief | Acrivastine | Respiratory System | No data available |
|
Allerief 4mg tablets
0304010G0BJABAC
|
Allerief | Chlorphenamine maleate | Respiratory System | No data available |
|
AllerTek 10mg tablets
0304010I0BIAAAA
|
Allertek | Cetirizine hydrochloride | Respiratory System | No data available |
|
Allevia Hives 180mg tablets
0304010E0BCABAB
|
Allevia | Fexofenadine hydrochloride | Respiratory System | No data available |
|
Alupent 10mg/5ml syrup
0301012S0BBABAG
|
Alupent | Orciprenaline sulfate | Respiratory System | No data available |
|
Alupent 20mg tablets
0301012S0BBAAAF
|
Alupent | Orciprenaline sulfate | Respiratory System | No data available |
|
Aminophylline 100mg tablets
0301030B0AAANAN
|
Aminophylline | Aminophylline | Respiratory System | No data available |
|
Aminophylline 250mg/10ml inj Minijet pre-filled syringes
0301030B0BCAAA9
|
Minjet (Aminophylline) | Aminophylline | Respiratory System | No data available |
|
Aminophylline 250mg/10ml inj pre-filled syringes
0301030B0AAA9A9
|
Aminophylline | Aminophylline | Respiratory System | No data available |
|
Aminophylline 360mg suppositories
0301030B0AAAMAM
|
Aminophylline | Aminophylline | Respiratory System | No data available |
|
Aminophylline hydrate 100mg modified-release tablets
0301030C0AAADAD
|
Aminophylline hydrate | Aminophylline hydrate | Respiratory System | No data available |
|
Ammonia and Ipecacuanha mixture
0309020B0AAACAC
|
Ammon bicarbonate | Ammonium bicarbonate | Respiratory System | No data available |
|
Ammonium acetate solution strong
0309020A0AAAAAA
|
Ammon acetate | Ammonium acetate | Respiratory System | No data available |
|
Amnivent-225 SR tablets
0301030B0BDAAAR
|
Amnivent-225 | Aminophylline | Respiratory System | No data available |
|
Anapen 300micrograms/0.3ml (1 in 1,000) inj auto-injectors
0304030C0BGAAA3
|
Anapen | Adrenaline | Respiratory System | No data available |
|
Anapen 500micrograms/0.3ml (1 in 600) inj auto-injectors
0304030C0BGACBE
|
Anapen | Adrenaline | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.